Go to main content

Press Releases

Explore the archived press releases about AOP Health, its products, studies and cooperations. We will be happy to answer any questions or comments you may have via aop-health@aoporphan.com 

AOP Orphan Statement on SARS-CoV-2 and COVID-19

17. 3. 2020

AOP Orphan hosted an Experts Press Conference at DGHO in Berlin

7. 10. 2019

AOP Orphan hosted Industry Symposium at DGHO in Berlin

7. 10. 2019

AOP Orphan announces EU Marketing Authorization for BESREMi® (Ropeginterferon alfa-2b) for rare blood cancer (PV)

21. 2. 2019

AOP Orphan announces positive CHMP opinion for Ropeginterferon alfa-2b/BESREMi®

17. 12. 2018

AOP Orphan announces three-year results on Ropeginterferon alfa-2b in Polycythemia Vera at the American Society of Hematology (ASH) Annual Meeting 2018

3. 12. 2018